{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:43:48Z","timestamp":1783561428010,"version":"3.55.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13365-019-00735-0","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T13:55:45Z","timestamp":1552485345000},"page":"673-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders"],"prefix":"10.1007","volume":"25","author":[{"given":"Jacqueline","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0661-4842","authenticated-orcid":false,"given":"William","family":"Tyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"issue":"16","key":"735_CR1","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1097\/00002030-200211080-00006","volume":"16","author":"S Abdulle","year":"2002","unstructured":"Abdulle S, Hagberg L, Svennerholm B, Fuchs D, Gissl\u00e9n M (2002) Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection. AIDS 16(16):2145\u20132149","journal-title":"AIDS"},{"issue":"8","key":"735_CR2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00415-006-0481-8","volume":"254","author":"S Abdulle","year":"2007","unstructured":"Abdulle S, Mellgren \u00c5, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gissl\u00e9n M (2007) CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration. J Neurol 254(8):1026\u20131032","journal-title":"J Neurol"},{"issue":"2","key":"735_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim CL et al (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J NeuroImmune Pharmacol 4(2):190\u2013199","journal-title":"J NeuroImmune Pharmacol"},{"issue":"6","key":"735_CR4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002516","volume":"3","author":"P Ancuta","year":"2008","unstructured":"Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, Wurcel A, Zaman T, Stone D, Mefford M, Morgello S, Singer EJ, Wolinsky SM, Gabuzda D (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3(6):e2516","journal-title":"PLoS One"},{"issue":"1","key":"735_CR5","first-page":"106","volume":"23","author":"AM Anderson","year":"2017","unstructured":"Anderson AM et al (2017) Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-infected individuals. J Neuro-Oncol 23(1):106\u2013112","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"735_CR6","first-page":"603","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Hirsch EC, Agid Y (1997) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 12(3):603\u2013610","journal-title":"Histol Histopathol"},{"issue":"4","key":"735_CR7","volume":"11","author":"HW Ann","year":"2016","unstructured":"Ann HW, Jun S, Shin NY, Han S, Ahn JY, Ahn MY, Jeon YD, Jung IY, Kim MH, Jeong WY, Ku NS, Kim JM, Smith DM, Choi JY (2016) Characteristics of resting-state functional connectivity in HIV-associated neurocognitive disorder. PLoS One 11(4):e0153493","journal-title":"PLoS One"},{"issue":"18","key":"735_CR8","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789\u20131799","journal-title":"Neurology"},{"issue":"13","key":"735_CR9","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0000000000001160","volume":"30","author":"EL Asahchop","year":"2016","unstructured":"Asahchop EL, Akinwumi SM, Branton WG, Fujiwara E, Gill MJ, Power C (2016) Plasma microRNA profiling predicts HIV-associated neurocognitive disorder. AIDS 30(13):2021\u20132031","journal-title":"AIDS"},{"issue":"3","key":"735_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:AIBE.0000044081.42034.54","volume":"8","author":"TT Baldewicz","year":"2004","unstructured":"Baldewicz TT, Leserman J, Silva SG, Petitto JM, Golden RN, Perkins DO, Barroso J, Evans DL (2004) Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation. AIDS Behav 8(3):345\u2013355","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"735_CR11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00002030-200418001-00003","volume":"18","author":"JT Becker","year":"2004","unstructured":"Becker JT et al (2004) Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11\u2013S18","journal-title":"AIDS"},{"issue":"2","key":"735_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","volume":"63","author":"K Bhaskaran","year":"2008","unstructured":"Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K, CASCADE Collaboration (2008) Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol 63(2):213\u2013221","journal-title":"Ann Neurol"},{"issue":"12","key":"735_CR13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","volume":"12","author":"JM Brenchley","year":"2006","unstructured":"Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12(12):1365\u20131371","journal-title":"Nat Med"},{"issue":"9","key":"735_CR14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 65(9):1490\u20131492","journal-title":"Neurology"},{"issue":"8","key":"735_CR15","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2105\/AJPH.2012.300844","volume":"102","author":"JT Brooks","year":"2012","unstructured":"Brooks JT, Buchacz K, Gebo KA, Mermin J (2012) HIV infection and older Americans: the public health perspective. Am J Public Health 102(8):1516\u20131526","journal-title":"Am J Public Health"},{"issue":"5","key":"735_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155766","volume":"11","author":"MJ Brouillette","year":"2016","unstructured":"Brouillette MJ, Yuen T, Fellows LK, Cysique LA, Heaton RK, Mayo NE (2016) Identifying neurocognitive decline at 36 months among HIV-positive participants in the CHARTER cohort using group-based trajectory analysis. PLoS One 11(5):e0155766","journal-title":"PLoS One"},{"issue":"4","key":"735_CR17","first-page":"382","volume":"17","author":"A Brown","year":"2011","unstructured":"Brown A et al (2011) Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals. J Neuro-Oncol 17(4):382\u2013392","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"735_CR18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/590504","volume":"198","author":"TH Burdo","year":"2008","unstructured":"Burdo TH, Ellis RJ, Fox HS (2008) Osteopontin is increased in HIV-associated dementia. J Infect Dis 198(5):715\u2013722","journal-title":"J Infect Dis"},{"issue":"9","key":"735_CR19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/QAD.0b013e32836010bd","volume":"27","author":"TH Burdo","year":"2013","unstructured":"Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC (2013) Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS 27(9):1387\u20131395","journal-title":"AIDS"},{"issue":"5","key":"735_CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1570162X14666160324125158","volume":"14","author":"Y Cai","year":"2016","unstructured":"Cai Y, Yang L, Callen S, Buch S (2016) Multiple faceted roles of cocaine in potentiation of HAND. Curr HIV Res 14(5):412\u2013416","journal-title":"Curr HIV Res"},{"issue":"1","key":"735_CR21","first-page":"88","volume":"22","author":"A Calcagno","year":"2016","unstructured":"Calcagno A et al (2016) Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. J Neuro-Oncol 22(1):88\u201392","journal-title":"J Neuro-Oncol"},{"key":"735_CR22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.12688\/f1000research.10651.1","volume":"6","author":"A Carroll","year":"2017","unstructured":"Carroll A, Brew B (2017) HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment. F1000Res 6:312","journal-title":"F1000Res"},{"issue":"5","key":"735_CR23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11481-013-9512-2","volume":"8","author":"E Cassol","year":"2013","unstructured":"Cassol E, Misra V, Morgello S, Gabuzda D (2013) Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection. J NeuroImmune Pharmacol 8(5):1087\u20131097","journal-title":"J NeuroImmune Pharmacol"},{"issue":"8","key":"735_CR24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3174\/ajnr.A5246","volume":"38","author":"JR Chaganti","year":"2017","unstructured":"Chaganti JR, Heinecke A, Gates TM, Moffat KJ, Brew BJ (2017) Functional connectivity in virally suppressed patients with HIV-associated neurocognitive disorder: a resting-state analysis. AJNR Am J Neuroradiol 38(8):1623\u20131629","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"735_CR25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.neuroimage.2004.07.067","volume":"23","author":"L Chang","year":"2004","unstructured":"Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA, HIV MRS Consortium (2004) A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 23(4):1336\u20131347","journal-title":"Neuroimage"},{"issue":"24","key":"735_CR26","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1212\/WNL.0000000000000526","volume":"82","author":"L Chang","year":"2014","unstructured":"Chang L, Jiang C, Cunningham E, Buchthal S, Douet V, Andres M, Ernst T (2014) Effects of APOE epsilon4, age, and HIV on glial metabolites and cognitive deficits. Neurology 82(24):2213\u20132222","journal-title":"Neurology"},{"issue":"6","key":"735_CR27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/aid.2012.0229","volume":"29","author":"S Chiao","year":"2013","unstructured":"Chiao S, Rosen HJ, Nicolas K, Wendelken LA, Alcantar O, Rankin KP, Miller B, Valcour V (2013) Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retrovir 29(6):949\u2013956","journal-title":"AIDS Res Hum Retrovir"},{"issue":"11","key":"735_CR28","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1007\/s11064-017-2358-x","volume":"42","author":"VT Ciavatta","year":"2017","unstructured":"Ciavatta VT, Bichler EK, Speigel IA, Elder CC, Teng SL, Tyor WR, Garc\u00eda PS (2017) In vitro and ex vivo neurotoxic effects of efavirenz are greater than those of other common antiretrovirals. Neurochem Res 42(11):3220\u20133232","journal-title":"Neurochem Res"},{"issue":"11","key":"735_CR29","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/j.1532-5415.2012.04213.x","volume":"60","author":"N Ciccarelli","year":"2012","unstructured":"Ciccarelli N, Fabbiani M, Baldonero E, Fanti I, Cauda R, Giambenedetto SD, Silveri MC (2012) Effect of aging and human immunodeficiency virus infection on cognitive abilities. J Am Geriatr Soc 60(11):2048\u20132055","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"735_CR30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s15010-013-0503-2","volume":"41","author":"N Ciccarelli","year":"2013","unstructured":"Ciccarelli N, Fabbiani M, Grima P, Falasca K, Tana M, Baldonero E, Colafigli M, Silveri MC, Vecchiet J, Cauda R, di Giambenedetto S (2013) Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients. Infection 41(6):1103\u20131109","journal-title":"Infection"},{"issue":"23","key":"735_CR31","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JSK (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73(23):1982\u20131987","journal-title":"Neurology"},{"issue":"1","key":"735_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13195-015-0123-4","volume":"7","author":"RA Cohen","year":"2015","unstructured":"Cohen RA, Seider TR, Navia B (2015) HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther 7(1):37","journal-title":"Alzheimers Res Ther"},{"issue":"14","key":"735_CR33","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1212\/WNL.0000000000003790","volume":"88","author":"JH Cole","year":"2017","unstructured":"Cole JH, Underwood J, Caan MW, de Francesco D, van Zoest R, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff M, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ, COBRA collaboration (2017) Increased brain-predicted aging in treated HIV disease. Neurology 88(14):1349\u20131357","journal-title":"Neurology"},{"issue":"3","key":"735_CR34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1176\/jnp.16.3.330","volume":"16","author":"SA Cristiani","year":"2004","unstructured":"Cristiani SA, Pukay-Martin ND, Bornstein RA (2004) Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci 16(3):330\u2013335","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"735_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/appi.neuropsych.23.1.83","volume":"23","author":"LA Cysique","year":"2011","unstructured":"Cysique LA, Maruff P, Bain MP, Wright E, Brew BJ (2011) HIV and age do not substantially interact in HIV-associated neurocognitive impairment. J Neuropsychiatry Clin Neurosci 23(1):83\u201389","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"735_CR36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120488","volume":"10","author":"LA Cysique","year":"2015","unstructured":"Cysique LA, Hey-Cunningham WJ, Dermody N, Chan P, Brew BJ, Koelsch KK (2015) Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition. PLoS One 10(4):e0120488","journal-title":"PLoS One"},{"issue":"4","key":"735_CR37","first-page":"539","volume":"23","author":"LA Cysique","year":"2017","unstructured":"Cysique LA et al (2017) White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration. J Neuro-Oncol 23(4):539\u2013547","journal-title":"J Neuro-Oncol"},{"issue":"15","key":"735_CR38","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","volume":"28","author":"V Dahl","year":"2014","unstructured":"Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW (2014) Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28(15):2251\u20132258","journal-title":"AIDS"},{"key":"735_CR39","doi-asserted-by":"crossref","first-page":"17094","DOI":"10.1038\/srep17094","volume":"5","author":"MF Oliveira de","year":"2015","unstructured":"de Oliveira MF et al (2015) Circulating HIV DNA correlates with neurocognitive impairment in older HIV-infected adults on suppressive ART. Sci Rep 5:17094","journal-title":"Sci Rep"},{"issue":"4","key":"735_CR40","first-page":"118","volume":"17","author":"SG Deeks","year":"2009","unstructured":"Deeks SG (2009) Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 17(4):118\u2013123","journal-title":"Top HIV Med"},{"issue":"15","key":"735_CR41","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1212\/WNL.0b013e31828c2e9e","volume":"80","author":"P Desplats","year":"2013","unstructured":"Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80(15):1415\u20131423","journal-title":"Neurology"},{"issue":"4","key":"735_CR42","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11065-015-9305-x","volume":"25","author":"S DeVaughn","year":"2015","unstructured":"DeVaughn S, M\u00fcller-Oehring EM, Markey B, Bront\u00eb-Stewart HM, Schulte T (2015) Aging with HIV-1 infection: motor functions, cognition, and attention--a comparison with Parkinson\u2019s disease. Neuropsychol Rev 25(4):424\u2013438","journal-title":"Neuropsychol Rev"},{"issue":"5","key":"735_CR43","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/QAD.0000000000000580","volume":"29","author":"AM Dickens","year":"2015","unstructured":"Dickens AM, Anthony DC, Deutsch R, Mielke MM, Claridge TD, Grant I, Franklin D, Rosario D, Marcotte T, Letendre S, McArthur J, Haughey NJ (2015) Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS 29(5):559\u2013569","journal-title":"AIDS"},{"issue":"6","key":"735_CR44","first-page":"875","volume":"23","author":"L Plessis du","year":"2017","unstructured":"du Plessis L et al (2017) Resting-state functional magnetic resonance imaging in clade C HIV: within-group association with neurocognitive function. J Neuro-Oncol 23(6):875\u2013885","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"735_CR45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pbb.2011.02.022","volume":"99","author":"JA Dumas","year":"2011","unstructured":"Dumas JA, Newhouse PA (2011) The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 99(2):254\u2013261","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"735_CR46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157160","volume":"11","author":"A Eden","year":"2016","unstructured":"Eden A et al (2016) Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment. PLoS One 11(6):e0157160","journal-title":"PLoS One"},{"issue":"14","key":"735_CR47","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","volume":"25","author":"RJ Ellis","year":"2011","unstructured":"Ellis RJ, Badiee J, Vaida F, Letendre S, Heaton RK, Clifford D, Collier AC, Gelman B, McArthur J, Morgello S, McCutchan J, Grant I, CHARTER Group (2011) CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS 25(14):1747\u20131751","journal-title":"AIDS"},{"issue":"5","key":"735_CR48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/jmri.22366","volume":"32","author":"T Ernst","year":"2010","unstructured":"Ernst T, Jiang CS, Nakama H, Buchthal S, Chang L (2010) Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging 32(5):1045\u20131053","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"735_CR49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-1293.2012.01044.x","volume":"14","author":"M Fabbiani","year":"2013","unstructured":"Fabbiani M, Ciccarelli N, Tana M, Farina S, Baldonero E, di Cristo V, Colafigli M, Tamburrini E, Cauda R, Silveri MC, Grima P, di Giambenedetto S (2013) Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med 14(3):136\u2013144","journal-title":"HIV Med"},{"issue":"2","key":"735_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11904-015-0257-9","volume":"12","author":"AF Fois","year":"2015","unstructured":"Fois AF, Brew BJ (2015) The potential of the CNS as a reservoir for HIV-1 infection: implications for HIV eradication. Curr HIV\/AIDS Rep 12(2):299\u2013303","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"735_CR51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11904-015-0266-8","volume":"12","author":"BB Gelman","year":"2015","unstructured":"Gelman BB (2015) Neuropathology of HAND with suppressive antiretroviral therapy: encephalitis and neurodegeneration reconsidered. Curr HIV\/AIDS Rep 12(2):272\u2013279","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"735_CR52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.25160","volume":"83","author":"SD Ginsberg","year":"2018","unstructured":"Ginsberg SD, Alldred MJ, Gunnam SM, Schiroli C, Lee SH, Morgello S, Fischer T (2018) Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol 83(2):406\u2013417","journal-title":"Ann Neurol"},{"key":"735_CR53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gisslen","year":"2016","unstructured":"Gisslen M et al (2016) Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine 3:135\u2013140","journal-title":"EBioMedicine"},{"issue":"11","key":"735_CR54","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.43.11.2230","volume":"43","author":"JD Glass","year":"1993","unstructured":"Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43(11):2230\u20132237","journal-title":"Neurology"},{"issue":"9","key":"735_CR55","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2352-3018(17)30098-X","volume":"4","author":"K Goodkin","year":"2017","unstructured":"Goodkin K, Miller EN, Cox C, Reynolds S, Becker JT, Martin E, Selnes OA, Ostrow DG, Sacktor NC, Multicenter AIDS Cohort Study (2017) Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study. Lancet HIV 4(9):e411\u2013e422","journal-title":"Lancet HIV"},{"issue":"23","key":"735_CR56","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK, For the CHARTER Group (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82(23):2055\u20132062","journal-title":"Neurology"},{"issue":"4","key":"735_CR57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19(4):407\u2013411","journal-title":"AIDS"},{"issue":"14","key":"735_CR58","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/QAD.0b013e32832d3b85","volume":"23","author":"C Grunfeld","year":"2009","unstructured":"Grunfeld C, Delaney JAC, Wanke C, Currier JS, Scherzer R, Biggs ML, Tien PC, Shlipak MG, Sidney S, Polak JF, O\u02bcLeary D, Bacchetti P, Kronmal RA (2009) Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 23(14):1841\u20131849","journal-title":"AIDS"},{"issue":"11","key":"735_CR59","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53(11):1120\u20131126","journal-title":"Clin Infect Dis"},{"issue":"4","key":"735_CR60","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/QAI.0000000000001111","volume":"73","author":"A Guha","year":"2016","unstructured":"Guha A, Brier MR, Ortega M, Westerhaus E, Nelson B, Ances BM (2016) Topographies of cortical and subcortical volume loss in HIV and aging in the cART era. J Acquir Immune Defic Syndr 73(4):374\u2013383","journal-title":"J Acquir Immune Defic Syndr"},{"key":"735_CR61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","volume":"7","author":"L Hagberg","year":"2010","unstructured":"Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D (2010) Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection. AIDS Res Ther 7:15","journal-title":"AIDS Res Ther"},{"issue":"5","key":"735_CR62","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","volume":"25","author":"J Harezlak","year":"2011","unstructured":"Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B, HIV Neuroimaging Consortium (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 25(5):625\u2013633","journal-title":"AIDS"},{"issue":"3","key":"735_CR63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1471-4159.2001.00396.x","volume":"78","author":"NJ Haughey","year":"2001","unstructured":"Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78(3):457\u2013467","journal-title":"J Neurochem"},{"issue":"23","key":"735_CR64","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, For the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087\u20132096","journal-title":"Neurology"},{"issue":"1","key":"735_CR65","first-page":"3","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK et al (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17(1):3\u201316","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"735_CR66","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, McCutchan JA, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Franklin D, Ellis RJ, McCutchan JA, Alexander T, Letendre S, Capparelli E, Heaton RK, Atkinson JH, Woods SP, Dawson M, Smith DM, Fennema-Notestine C, Taylor MJ, Theilmann R, Gamst AC, Cushman C, Abramson I, Vaida F, Marcotte TD, Marquie-Beck J, McArthur J, Rogalski V, Morgello S, Simpson D, Mintz L, McCutchan JA, Toperoff W, Collier A, Marra C, Jones T, Gelman B, Head E, Clifford D, al-Lozi M, Teshome M (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473\u2013480","journal-title":"Clin Infect Dis"},{"issue":"4","key":"735_CR67","first-page":"291","volume":"18","author":"JL Holt","year":"2012","unstructured":"Holt JL, Kraft-Terry SD, Chang L (2012) Neuroimaging studies of the aging HIV-1-infected brain. J Neuro-Oncol 18(4):291\u2013302","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"735_CR68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S1355617715000156","volume":"21","author":"JC Ipser","year":"2015","unstructured":"Ipser JC, Brown GG, Bischoff-Grethe A, Connolly CG, Ellis RJ, Heaton RK, Grant I, Translational Methamphetamine AIDS Research Center (TMARC) Group (2015) HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study. J Int Neuropsychol Soc 21(3):203\u2013213","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"735_CR69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/13803395.2011.651103","volume":"34","author":"JE Iudicello","year":"2012","unstructured":"Iudicello JE, Woods SP, Deutsch R, Grant I, The HIV Neurobehavioral Research Pr (2012) Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol 34(5):476\u2013488","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"735_CR70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088591","volume":"9","author":"J Jessen Krut","year":"2014","unstructured":"Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gissl\u00e9n M (2014) Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One 9(2):e88591","journal-title":"PLoS One"},{"issue":"5","key":"735_CR71","first-page":"377","volume":"16","author":"JA Joska","year":"2010","unstructured":"Joska JA et al (2010) Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neuro-Oncol 16(5):377\u2013383","journal-title":"J Neuro-Oncol"},{"issue":"8","key":"735_CR72","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s10461-016-1316-y","volume":"20","author":"JA Joska","year":"2016","unstructured":"Joska JA, Witten J, Thomas KG, Robertson C, Casson-Crook M, Roosa H, Creighton J, Lyons J, McArthur J, Sacktor NC (2016) A comparison of five brief screening tools for HIV-associated neurocognitive disorders in the USA and South Africa. AIDS Behav 20(8):1621\u20131631","journal-title":"AIDS Behav"},{"key":"735_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1329-9","author":"AR Kallianpur","year":"2018","unstructured":"Kallianpur AR, et al. (2018) Cerebrospinal fluid ceruloplasmin, haptoglobin, and vascular endothelial growth factor are associated with neurocognitive impairment in adults with HIV infection. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-018-1329-9","journal-title":"Mol Neurobiol"},{"issue":"3","key":"735_CR74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/QAI.0b013e318256f3bc","volume":"60","author":"A Kamat","year":"2012","unstructured":"Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Singer EJ, Gabuzda D (2012) Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr 60(3):234\u2013243","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"735_CR75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s40473-017-0122-9","volume":"4","author":"A Kamkwalala","year":"2017","unstructured":"Kamkwalala A, Newhouse P (2017) Mechanisms of cognitive aging in the HIV-positive adult. Curr Behav Neurosci Rep 4(3):188\u2013197","journal-title":"Curr Behav Neurosci Rep"},{"issue":"1","key":"735_CR76","first-page":"9","volume":"20","author":"R Koneru","year":"2014","unstructured":"Koneru R, Olive MF, Tyor WR (2014) Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model. J Neuro-Oncol 20(1):9\u201317","journal-title":"J Neuro-Oncol"},{"issue":"11","key":"735_CR77","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/QAD.0000000000001836","volume":"32","author":"R Koneru","year":"2018","unstructured":"Koneru R, Bimonte-Nelson H, Ciavatta V, Haile W, Elmore K, Ward J, Maroun L, Tyor WR (2018) Reversing interferon-alpha neurotoxicity in a HIV-associated neurocognitive disorder mouse model. AIDS 32(11):1403\u20131411","journal-title":"AIDS"},{"issue":"3","key":"735_CR78","first-page":"257","volume":"15","author":"AM Kumar","year":"2009","unstructured":"Kumar AM et al (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neuro-Oncol 15(3):257\u2013274","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"735_CR79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1176\/appi.neuropsych.11050109","volume":"24","author":"I Kusao","year":"2012","unstructured":"Kusao I, Shiramizu B, Liang CY, Grove J, Agsalda M, Troelstrup D, Velasco VN, Marshall A, Whitenack N, Shikuma C, Valcour V (2012) Cognitive performance related to HIV-1-infected monocytes. J Neuropsychiatry Clin Neurosci 24(1):71\u201380","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Suppl 2","key":"735_CR80","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1097\/QAD.0000000000001441","volume":"31","author":"C Lagathu","year":"2017","unstructured":"Lagathu C, Cossarizza A, B\u00e9r\u00e9ziat V, Nasi M, Capeau J, Pinti M (2017) Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers. AIDS 31(Suppl 2):S105\u2013S119","journal-title":"AIDS"},{"issue":"3","key":"735_CR81","first-page":"366","volume":"22","author":"AJ Levine","year":"2016","unstructured":"Levine AJ et al (2016) Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neuro-Oncol 22(3):366\u2013375","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"735_CR82","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","volume":"10","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, Kornhuber J, Blennow K, Zetterberg H (2018) Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease. Alzheimers Res Ther 10(1):71","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"735_CR83","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/13803395.2010.518140","volume":"33","author":"K Lin","year":"2011","unstructured":"Lin K, Taylor MJ, Heaton R, Franklin D, Jernigan T, Fennema-Notestine C, McCutchan A, Atkinson JH, Ellis RJ, McArthur J, Morgello S, Simpson D, Collier AC, Marra C, Gelman B, Clifford D, Grant I, CHARTER group (2011) Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol 33(3):326\u2013334","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"735_CR84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","volume":"57","author":"JL Lyons","year":"2011","unstructured":"Lyons JL, Uno H, Ancuta P, Kamat A, Moore DJ, Singer EJ, Morgello S, Gabuzda D (2011) Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr 57(5):371\u2013379","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"735_CR85","first-page":"110","volume":"17","author":"L Malaspina","year":"2011","unstructured":"Malaspina L et al (2011) Successful cognitive aging in persons living with HIV infection. J Neuro-Oncol 17(1):110\u2013119","journal-title":"J Neuro-Oncol"},{"issue":"12","key":"735_CR86","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","volume":"61","author":"C Malmestrom","year":"2003","unstructured":"Malmestrom C, Haghighi S, Rosengren L, Andersen O, Lycke J (2003) Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology 61(12):1720\u20131725","journal-title":"Neurology"},{"issue":"5","key":"735_CR87","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, for the Alzheimer\u2019s Disease Neuroimaging Initiative (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74(5):557\u2013566","journal-title":"JAMA Neurol"},{"issue":"6","key":"735_CR88","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","volume":"67","author":"JC McArthur","year":"2010","unstructured":"McArthur JC et al (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67(6):699\u2013714","journal-title":"Ann Neurol"},{"issue":"4","key":"735_CR89","first-page":"439","volume":"21","author":"JL McGuire","year":"2015","unstructured":"McGuire JL et al (2015) Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neuro-Oncol 21(4):439\u2013448","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"735_CR90","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11481-013-9458-4","volume":"8","author":"B Megra","year":"2013","unstructured":"Megra B, Eugenin E, Roberts T, Morgello S, Berman JW (2013) Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND. J NeuroImmune Pharmacol 8(5):1159\u20131166","journal-title":"J NeuroImmune Pharmacol"},{"issue":"3","key":"735_CR91","first-page":"358","volume":"22","author":"RI Melendez","year":"2016","unstructured":"Melendez RI et al (2016) Decreased glial and synaptic glutamate uptake in the striatum of HIV-1 gp120 transgenic mice. J Neuro-Oncol 22(3):358\u2013365","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"735_CR92","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11904-017-0361-0","volume":"14","author":"B Milanini","year":"2017","unstructured":"Milanini B, Valcour V (2017) Differentiating HIV-associated neurocognitive disorders from Alzheimer\u2019s disease: an emerging issue in geriatric NeuroHIV. Curr HIV\/AIDS Rep 14(4):123\u2013132","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"735_CR93","first-page":"575","volume":"22","author":"B Milanini","year":"2016","unstructured":"Milanini B et al (2016) Cognitive reserve and neuropsychological functioning in older HIV-infected people. J Neuro-Oncol 22(5):575\u2013583","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"735_CR94","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jalz.2014.03.003","volume":"10","author":"JL Molinuevo","year":"2014","unstructured":"Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L (2014) The clinical use of cerebrospinal fluid biomarker testing for Alzheimer\u2019s disease diagnosis: a consensus paper from the Alzheimer\u2019s Biomarkers Standardization Initiative. Alzheimers Dement 10(6):808\u2013817","journal-title":"Alzheimers Dement"},{"issue":"2","key":"735_CR95","first-page":"150","volume":"19","author":"EE Morgan","year":"2013","unstructured":"Morgan EE et al (2013) Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neuro-Oncol 19(2):150\u2013156","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"735_CR96","first-page":"571","volume":"20","author":"LC Ndhlovu","year":"2014","unstructured":"Ndhlovu LC et al (2014) Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND). J Neuro-Oncol 20(6):571\u2013582","journal-title":"J Neuro-Oncol"},{"key":"735_CR97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jneuroim.2015.08.020","volume":"288","author":"LC Ndhlovu","year":"2015","unstructured":"Ndhlovu LC, D'Antoni ML, Ananworanich J, Byron MM, Chalermchai T, Sithinamsuwan P, Tipsuk S, Ho E, Slike BM, Schuetz A, Zhang G, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Valcour V, SEARCH 011 study group (2015) Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naive HIV-infected Thais. J Neuroimmunol 288:25\u201333","journal-title":"J Neuroimmunol"},{"issue":"Suppl 2","key":"735_CR98","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1097\/QAD.0000000000001402","volume":"31","author":"S Nightingale","year":"2017","unstructured":"Nightingale S, Winston A (2017) Measuring and managing cognitive impairment in HIV. AIDS 31(Suppl 2):S165\u2013S172","journal-title":"AIDS"},{"issue":"11","key":"735_CR99","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T (2014) Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13(11):1139\u20131151","journal-title":"Lancet Neurol"},{"issue":"3","key":"735_CR100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/hbm.22228","volume":"35","author":"TM Nir","year":"2014","unstructured":"Nir TM, Jahanshad N, Busovaca E, Wendelken L, Nicolas K, Thompson PM, Valcour VG (2014) Mapping white matter integrity in elderly people with HIV. Hum Brain Mapp 35(3):975\u2013992","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"735_CR101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0006-8993(03)03219-0","volume":"987","author":"N Norgren","year":"2003","unstructured":"Norgren N, Rosengren L, Stigbrand T (2003) Elevated neurofilament levels in neurological diseases. Brain Res 987(1):25\u201331","journal-title":"Brain Res"},{"issue":"4","key":"735_CR102","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11481-014-9546-0","volume":"9","author":"M Ortega","year":"2014","unstructured":"Ortega M, Ances BM (2014) Role of HIV in amyloid metabolism. J NeuroImmune Pharmacol 9(4):483\u2013491","journal-title":"J NeuroImmune Pharmacol"},{"issue":"7","key":"735_CR103","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/gerona\/glt168","volume":"69","author":"S Pathai","year":"2014","unstructured":"Pathai S, Bajillan H, Landay AL, High KP (2014) Is HIV a model of accelerated or accentuated aging? J Gerontol A Biol Sci Med Sci 69(7):833\u2013842","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"735_CR104","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/infdis\/jit088","volume":"207","author":"MJ Peluso","year":"2013","unstructured":"Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslen M, Spudich S (2013) Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. J Infect Dis 207(11):1703\u20131712","journal-title":"J Infect Dis"},{"issue":"3","key":"735_CR105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256(3):183\u2013194","journal-title":"J Intern Med"},{"issue":"3","key":"735_CR106","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L (2014) Mild cognitive impairment: a concept in evolution. J Intern Med 275(3):214\u2013228","journal-title":"J Intern Med"},{"issue":"3","key":"735_CR107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","volume":"90","author":"RC Petersen","year":"2018","unstructured":"Petersen RC et al (2018) Practice guideline update summary: mild cognitive impairment: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 90(3):126\u2013135","journal-title":"Neurology"},{"issue":"12","key":"735_CR108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116081","volume":"9","author":"J Peterson","year":"2014","unstructured":"Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW (2014) Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One 9(12):e116081","journal-title":"PLoS One"},{"issue":"7","key":"735_CR109","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.neurobiolaging.2014.01.008","volume":"35","author":"A Pfefferbaum","year":"2014","unstructured":"Pfefferbaum A, Rogosa DA, Rosenbloom MJ, Chu W, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Zahr NM, Sullivan EV (2014) Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging 35(7):1755\u20131768","journal-title":"Neurobiol Aging"},{"key":"735_CR110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, Galluzzi S, Marizzoni M, Frisoni GB (2016) Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev 30:25\u201348","journal-title":"Ageing Res Rev"},{"issue":"6","key":"735_CR111","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/QAD.0000000000000151","volume":"28","author":"SD Plessis","year":"2014","unstructured":"Plessis SD, Vink M, Joska JA, Koutsilieri E, Stein DJ, Emsley R (2014) HIV infection and the fronto-striatal system: a systematic review and meta-analysis of fMRI studies. AIDS 28(6):803\u2013811","journal-title":"AIDS"},{"key":"735_CR112","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-018-0696-3","author":"TA Premeaux","year":"2018","unstructured":"Premeaux TA, et al. (2018) Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals J Neuro-Oncol. https:\/\/doi.org\/10.1007\/s13365-018-0696-3","journal-title":"J Neuro-Oncol"},{"key":"735_CR113","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-018-0695-4","author":"L Pulliam","year":"2019","unstructured":"Pulliam L, et al. (2019) Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer\u2019s disease. J Neuro-Oncol. https:\/\/doi.org\/10.1007\/s13365-018-0695-4","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"735_CR114","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19(2):127\u2013135","journal-title":"AIDS"},{"issue":"4","key":"735_CR115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/brbi.1995.1034","volume":"9","author":"MB Rho","year":"1995","unstructured":"Rho MB, Wesselingh S, Glass JD, Mcarthur JC, Choi S, Griffin J, Tyor WR (1995) A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav Immun 9(4):366\u2013377","journal-title":"Brain Behav Immun"},{"issue":"1","key":"735_CR116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","volume":"10","author":"JD Rippeth","year":"2004","unstructured":"Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R, Wolfson T, Grant I, HNRC Group (2004) Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10(1):1\u201314","journal-title":"J Int Neuropsychol Soc"},{"issue":"16","key":"735_CR117","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","volume":"74","author":"KR Robertson","year":"2010","unstructured":"Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, Evans S, Skiest DJ, For the A5170 Study Team (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74(16):1260\u20131266","journal-title":"Neurology"},{"issue":"4","key":"735_CR118","first-page":"472","volume":"22","author":"K Robertson","year":"2016","unstructured":"Robertson K et al (2016) International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neuro-Oncol 22(4):472\u2013478","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"735_CR119","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkels\u00f8 C (1996) Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem 67(5):2013\u20132018","journal-title":"J Neurochem"},{"issue":"3","key":"735_CR120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/CPJ.0000000000000117","volume":"5","author":"JA Rumbaugh","year":"2015","unstructured":"Rumbaugh JA, Tyor W (2015) HIV-associated neurocognitive disorders: five new things. Neurol Clin Pract 5(3):224\u2013231","journal-title":"Neurol Clin Pract"},{"issue":"6","key":"735_CR121","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/323036","volume":"184","author":"LA Ryan","year":"2001","unstructured":"Ryan LA, Zheng J, Brester M, Bohac D, Hahn F, Anderson J, Ratanasuwan W, Gendelman HE, Swindells S (2001) Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection. J Infect Dis 184(6):699\u2013706","journal-title":"J Infect Dis"},{"issue":"4","key":"735_CR122","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","volume":"86","author":"N Sacktor","year":"2016","unstructured":"Sacktor N, Skolasky RL, Seaberg E, Munro C, Becker JT, Martin E, Ragin A, Levine A, Miller E (2016) Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study. Neurology 86(4):334\u2013340","journal-title":"Neurology"},{"issue":"7","key":"735_CR123","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/QAD.0000000000001017","volume":"30","author":"J Schouten","year":"2016","unstructured":"Schouten J, Su T, Wit FW, Kootstra NA, Caan MW, Geurtsen GJ, Schmand BA, Stolte IG, Prins M, Majoie CB, Portegies P, Reiss P, AGEhIV Study Group (2016) Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy. AIDS 30(7):1027\u20131038","journal-title":"AIDS"},{"issue":"11","key":"735_CR124","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","volume":"63","author":"JJ Sevigny","year":"2004","unstructured":"Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K (2004) Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63(11):2084\u20132090","journal-title":"Neurology"},{"issue":"5","key":"735_CR125","first-page":"576","volume":"21","author":"DP Sheppard","year":"2015","unstructured":"Sheppard DP et al (2015) Elevated rates of mild cognitive impairment in HIV disease. J Neuro-Oncol 21(5):576\u2013584","journal-title":"J Neuro-Oncol"},{"key":"735_CR126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-63849-6.00007-4","volume":"152","author":"RC Smail","year":"2018","unstructured":"Smail RC, Brew BJ (2018) HIV-associated neurocognitive disorder. Handb Clin Neurol 152:75\u201397","journal-title":"Handb Clin Neurol"},{"issue":"10","key":"735_CR127","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/QAD.0b013e328339e25c","volume":"24","author":"SA Spector","year":"2010","unstructured":"Spector SA, Singh KK, Gupta S, Cystique LA, Jin H, Letendre S, Schrier R, Wu Z, Hong KX, Yu X, Shi C, Heaton RK, HNRC Group (2010) APOE epsilon4 and MBL-2 O\/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS 24(10):1471\u20131479","journal-title":"AIDS"},{"issue":"2","key":"735_CR128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneur.55.2.161","volume":"55","author":"JC Stout","year":"1998","unstructured":"Stout, J.C., Ellis R.J., Jernigan T.L., Archibald S.L., Abramson I., Wolfson T., McCutchan J., Wallace M.R., Atkinson J.H., Grant I., Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol, 1998. 55(2): p. 161\u2013168","journal-title":"Arch Neurol"},{"issue":"15","key":"735_CR129","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/QAD.0000000000001133","volume":"30","author":"T Su","year":"2016","unstructured":"Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB, AGEhIV Cohort Study (2016) White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS 30(15):2329\u20132339","journal-title":"AIDS"},{"issue":"2","key":"735_CR130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1570162X12666140526114956","volume":"12","author":"E Tavazzi","year":"2014","unstructured":"Tavazzi E, Morrison D, Sullivan P, Morgello S, Fischer T (2014) Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection. Curr HIV Res 12(2):97\u2013110","journal-title":"Curr HIV Res"},{"key":"735_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dadm.2016.03.009","volume":"4","author":"RS Turner","year":"2016","unstructured":"Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G (2016) An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst) 4:1\u20135","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"735_CR132","first-page":"180","volume":"24","author":"WR Tyor","year":"2018","unstructured":"Tyor WR, Bimonte-Nelson H (2018) A mouse model of HIV-associated neurocognitive disorders: a brain-behavior approach to discover disease mechanisms and novel treatments. J Neuro-Oncol 24(2):180\u2013184","journal-title":"J Neuro-Oncol"},{"issue":"5","key":"735_CR133","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11904-016-0324-x","volume":"13","author":"J Underwood","year":"2016","unstructured":"Underwood J, Winston A (2016) Guidelines for evaluation and management of cognitive disorders in HIV-positive individuals. Curr HIV\/AIDS Rep 13(5):235\u2013240","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1\u20132","key":"735_CR134","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jneuroim.2004.08.029","volume":"157","author":"V Valcour","year":"2004","unstructured":"Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, Grove J, Liu Y, Abdul-Majid KB, Gartner S, Sacktor N (2004) Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 157(1\u20132):197\u2013202","journal-title":"J Neuroimmunol"},{"issue":"5","key":"735_CR135","first-page":"362","volume":"14","author":"V Valcour","year":"2008","unstructured":"Valcour V et al (2008a) Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J Neuro-Oncol 14(5):362\u2013367","journal-title":"J Neuro-Oncol"},{"issue":"41","key":"735_CR136","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1073\/pnas.0806919105","volume":"105","author":"V Valcour","year":"2008","unstructured":"Valcour V, Shiramizu B, Shikuma C (2008b) Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival. Proc Natl Acad Sci U S A 105(41):E66 author reply E67\u20138","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"735_CR137","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1189\/jlb.0809571","volume":"87","author":"VG Valcour","year":"2010","unstructured":"Valcour VG, Shiramizu BT, Shikuma CM (2010) HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications. J Leukoc Biol 87(4):621\u2013626","journal-title":"J Leukoc Biol"},{"issue":"1","key":"735_CR138","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1017\/S1355617710001438","volume":"17","author":"V Valcour","year":"2011","unstructured":"Valcour V, Paul R, Neuhaus J, Shikuma C (2011) The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 17(1):190\u2013195","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"735_CR139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070164","volume":"8","author":"VG Valcour","year":"2013","unstructured":"Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, Shikuma C, Liang CY, Jirajariyavej S, Sithinamsuwan P, Tipsuk S, Clifford DB, Paul R, Fletcher JLK, Marovich MA, Slike BM, DeGruttola V, Shiramizu B, for the SEARCH 011 Protocol Team (2013) HIV DNA reservoir increases risk for cognitive disorders in cART-naive patients. PLoS One 8(7):e70164","journal-title":"PLoS One"},{"key":"735_CR140","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1743-422X-9-174","volume":"9","author":"M Vassallo","year":"2012","unstructured":"Vassallo M, Merci\u00e9 P, Cottalorda J, Ticchioni M, Dellamonica P (2012) The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J 9:174","journal-title":"Virol J"},{"issue":"4","key":"735_CR141","first-page":"376","volume":"19","author":"M Vassallo","year":"2013","unstructured":"Vassallo M et al (2013) Relevance of lipopolysaccharide levels in HIV-associated neurocognitive impairment: the Neuradapt study. J Neuro-Oncol 19(4):376\u2013382","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"735_CR142","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/1971400918782327","volume":"31","author":"N Ventura","year":"2018","unstructured":"Ventura N, Douw L, Correa DG, Netto TM, Cabral RF, Lopes FCR, Gasparetto EL (2018) Increased posterior cingulate cortex efficiency may predict cognitive impairment in asymptomatic HIV patients. Neuroradiol J 31(4):372\u2013378","journal-title":"Neuroradiol J"},{"issue":"15","key":"735_CR143","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0000000000002485","volume":"86","author":"JH Vera","year":"2016","unstructured":"Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, Rabiner EA, Kalk N, Bishop C, Gunn RN, Matthews PM, Winston A (2016) Neuroinflammation in treated HIV-positive individuals: a TSPO PET study. Neurology 86(15):1425\u20131432","journal-title":"Neurology"},{"issue":"4","key":"735_CR144","first-page":"256","volume":"18","author":"LA Wendelken","year":"2012","unstructured":"Wendelken LA, Valcour V (2012) Impact of HIV and aging on neuropsychological function. J Neuro-Oncol 18(4):256\u2013263","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"735_CR145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/QAI.0000000000001091","volume":"73","author":"LA Wendelken","year":"2016","unstructured":"Wendelken LA, Jahanshad N, Rosen HJ, Busovaca E, Allen I, Coppola G, Adams C, Rankin KP, Milanini B, Clifford K, Wojta K, Nir TM, Gutman BA, Thompson PM, Valcour V (2016) ApoE epsilon4 is associated with cognition, brain integrity, and atrophy in HIV over age 60. J Acquir Immune Defic Syndr 73(4):426\u2013432","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"735_CR146","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","volume":"19","author":"SP Woods","year":"2009","unstructured":"Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19(2):152\u2013168","journal-title":"Neuropsychol Rev"},{"issue":"2","key":"735_CR147","first-page":"144","volume":"19","author":"L Yuan","year":"2013","unstructured":"Yuan L et al (2013) Cytokines in CSF correlate with HIV-associated neurocognitive disorders in the post-HAART era in China. J Neuro-Oncol 19(2):144\u2013149","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"735_CR148","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","volume":"73","author":"H Zetterberg","year":"2016","unstructured":"Zetterberg H, Skillb\u00e4ck T, Mattsson N, Trojanowski JQ, Portelius E, Shaw LM, Weiner MW, Blennow K, for the Alzheimer\u2019s Disease Neuroimaging Initiative (2016) Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression. JAMA Neurol 73(1):60\u201367","journal-title":"JAMA Neurol"},{"issue":"15","key":"735_CR149","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1097\/QAD.0b013e328363bf56","volume":"27","author":"AR Zipursky","year":"2013","unstructured":"Zipursky AR, Gogolishvili D, Rueda S, Brunetta J, Carvalhal A, McCombe JA, Gill MJ, Rachlis A, Rosenes R, Arbess G, Marcotte T, Rourke SB (2013) Evaluation of brief screening tools for neurocognitive impairment in HIV\/AIDS: a systematic review of the literature. AIDS 27(15):2385\u20132401","journal-title":"AIDS"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-019-00735-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T19:29:48Z","timestamp":1721071788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-019-00735-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":149,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00735-0","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}